We're delighted to present the EATRIS Annual Report for 2023, showcasing our activities and highlights from the past year. The report embodies the tireless efforts and dedication of the entire EATRIS community to improving patient lives. 👉 Explore the full report here: https://lnkd.in/dzpF2Bpb
EATRIS
Onderzoeksdiensten
Amsterdam, Noord Holland 5.597 volgers
Resources and services for research communities to translate scientific discoveries into patient benefit
Over ons
EATRIS is the European infrastructure for translational medicine. We bring together resources and services for research communities to translate scientific discoveries into benefits for patients. We provide access to a vast array of pre-clinical and clinical expertise and facilities that are available within 115+ top-tier academic centres across Europe. We focus on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcome barriers to health innovation. Our research infrastructure offers a broad range of research services for both academia and industry across various research fields. In addition, we work with public funding agencies, charities and policy makers with tailored actions to help improve the translational research and innovation ecosystem.
- Website
-
https://eatris.eu/
Externe link voor EATRIS
- Branche
- Onderzoeksdiensten
- Bedrijfsgrootte
- 51 - 200 medewerkers
- Hoofdkantoor
- Amsterdam, Noord Holland
- Type
- Non-profit
- Specialismen
- Research Infrastructures, Translational Medicine, Matchmaking, Regulatory Advice, Vaccines, ATMP, Biomarkers, Small Molecules, Education and Training en Imaging and Tracing
Locaties
-
Primair
Routebeschrijving
De Boelelaan 1118
Amsterdam, Noord Holland 1081 HZ, NL
Medewerkers van EATRIS
-
Saco de Visser
Scientific Director Future Affordable and Sustainable Therapies
-
Lucia Gabriele
Head of Tumor Immunology Section, Dept. of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
-
Martin de Kort ☀
Senior Scientific Program Manager Translational Medicine & Drug Development
-
Alain van Gool
Professor Personalized Healthcare and scientist in the Translational Metabolic Laboratory at Radboudumc
Updates
-
EATRIS took part in the Biocat panel at the Tech Spirit Barcelona event recently. Anna Sanchez, PhD (EATRIS Innovation Manager) joined an inspiring discussion on “A Joint Trip to Health Deep-Tech Frontiers” moderated by Biocat, BioRegion of Catalonia Strategic Foresight and International Relations Director Montse Daban Marín. 👉 Read more about the event here: https://lnkd.in/dTCV4X5T
-
-
EATRIS is a partner of the Open Science Clusters’ Action for Research and Society - OSCARS project. The launch of the 2nd OSCARS Open Call for #OpenScience projects is set for January 2025. The call is open for researchers and organisations (RIs, universities, institutes, consortia) from all scientific domains. 👉 Join the event on 15 Jan to hear more: https://lnkd.in/dETCjxUX
-
-
Want to receive all the latest news & updates from our community & beyond? Sign up to receive our monthly updates here: https://lnkd.in/dYz8w3xB 📧 *Note you need to be from one of our 150+ EATRIS institutes to sign up!
-
The FAST - Centre for Future Affordable Sustainable Therapy Development has launched a Handbook for ATMP Developers, offering essential guidance for researchers navigating the development and regulatory journey of Advanced Therapy Medicinal Products (#ATMPs). Saco de Visser (Scientific Director at FAST and Governor of #EATRIS_NL) comments: ”Access to ATMPs is critical for patients, as these innovative therapies offer transformative potential for conditions that current treatments cannot adequately address. However, the complex regulatory pathways and specific requirements can hinder timely, affordable and sustainable access. It's essential that we bridge these gaps, ensuring clarity for developers and fostering a healthcare system where patients can benefit from these groundbreaking advancements.” 👉 Find out more here: https://lnkd.in/drywnnnz
-
-
Anna Sanchez (EATRIS Innovation Manager) was recently a panellist at the TechSpirit Barcelona event. The discussion was around navigating #DeepTech solutions in healthcare. 👉 Find out more here: https://lnkd.in/dTn3U_66 🎥 by Tech Barcelona
-
❗Last chance to join the European Rare Diseases Research Alliance (ERDERA) webinar on the Joint Transnational Call (JTC) for Proposals 2025. 👉 Sign up before 14.00 CET today (17 December) here: https://lnkd.in/dcbht6Gg
-
The #iDR25 tea has announced that Barbara Goodman, President & CEO of Cures Within Reach, will be speaking at the international #DrugRepurposing Congress in Amsterdam in May 2025. Barbara has 25+ years of experience in #BiomedicalInnovation in both for-profit and non-profit sectors. From leading iBIO’s PROPEL programme supporting early-stage life science ventures in Illinois — to shaping strategies at top organisations, her session is one not to miss! 👉 Find out more & book your early bird ticket here: https://lnkd.in/eb32WZd5
-
-
💡 EATRIS is co-hosting a free workshop in Berlin with National Center for Advancing Translational Sciences (NCATS), EU-OPENSCREEN, and Nuvisan CDD Holding GmbH. Join the "Assay Guidance Workshop for High-Throughput Screening and Lead Discovery" event on 9-10 April 2025. 💊 This in-depth workshop offers cutting-edge insights and practical tools for developing robust, reproducible assays in drug discovery and high-throughput screening. Ideal for researchers aiming to improve translational potential in #DrugDiscovery. Stay a bit longer for Nuvisan and EU-OPENSCREEN facilities tours in Berlin on 11 April. 👉 Find out more here: https://lnkd.in/dFqEx7fR
-